NCT01484210 - Single Dose Study of the Fluticasone/Salmeterol (500/50 μg) Administered With Elpenhaler® Versus Diskus® | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

October 31, 2008

Conditions

Asthma

Interventions

DRUG

Elpenhaler active - Diskus placebo

randomized, double-blind, double-dummy, 2-way crossover, single dose study, comparing the efficacy and safety of the Fluticasone/Salmeterol (500/50 μg) combination administered with Elpenhaler® (Rolenium®) versus the innovative one (Seretide Diskus®) in patients with asthma.

Trial Locations (5)

1536

Pneumology surgery Hostinskeho 1536, Prague

19800

Pneumology surgery Generala Janouska 902/17, Prague

56001

Pneumology surgery Vitezna 201/31, Karlovy Vary

Unknown

Pneumology surgery Vojtesska 237, Kutná Hora

337 01

Pneumology and allergology surgery Voldusska 750, New Town